China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study of Sonrotoclax Combined With Glofitamab and GemOx for Relapsed or Refractory Large B-Cell Lymphoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131690
Registration Time: 2026/09/05
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of Soochow University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339816
Published by HT Digital Content Services with permission from Health Daily Digest....